BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| ß-glucan {Beta-Glucan} - Muribaculaceae |
📓
Dietary Polycan, a ß-glucan originating from Aureobasidium pullulansSM-2001, attenuates high-fat-diet-induced intestinal barrier damage in obese mice by modulating gut microbiota dysbiosis. Food science & nutrition (Food Sci Nutr ) Vol: 12 Issue 8 Pages: 5824-5835 Pub: 2024 Aug Epub: 2024 May 26 Authors Ko GP , Unno T , Kim YS , Kim J , Html Article Publication |
| ß-glucan {Beta-Glucan} - Muribaculaceae |
📓
The Immunomodulatory Effect of ß-Glucan Depends on the Composition of the Gut Microbiota. Foods (Basel, Switzerland) (Foods ) Vol: 12 Issue 17 Pages: Pub: 2023 Aug 22 Epub: 2023 Aug 22 Authors Sung M , Yoon Y , Lee J , Html Article Publication |
| ß-glucan {Beta-Glucan} - Muribaculaceae |
👪
Effect of the ß-glucan from Lentinus edodes on colitis-associated colorectal cancer and gut microbiota. Carbohydrate polymers (Carbohydr Polym ) Vol: 316 Issue Pages: 121069 Pub: 2023 Sep 15 Epub: 2023 May 26 Authors Liu N , Zou S , Xie C , Meng Y , Xu X , Publication |
| ß-glucan {Beta-Glucan} - Muribaculaceae |
📓
ß-Glucan alleviates mice with ulcerative colitis through interactions between gut microbes and amino acids metabolism. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 103 Issue 8 Pages: 4006-4016 Pub: 2023 Jun Epub: 2022 Dec 7 Authors Liu C , Sun C , Cheng Y , Publication |
| ß-glucan {Beta-Glucan} - Muribaculaceae |
📓
Effects of Oat ß-Glucan and Inulin on Alleviation of Nonalcoholic Steatohepatitis Aggravated by Circadian Disruption in C57BL/6J Mice. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 72 Issue 7 Pages: 3520-3535 Pub: 2024 Feb 21 Epub: 2024 Feb 9 Authors Kei N , Cheung KK , Ma KL , Yau TK , Lauw S , Wong VWS , You L , Cheung PCK , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
